- A coronavirus vaccine study by Johnson & Johnson has been put on pause after one of the study’s participants had an “unexpected illness.”
- Johnson & Johnson has not said what type of illness the participant of the 60,000-person trial encountered. Further details, including the age and the gender of the participant, have also not been revealed.
- News about the pause comes just weeks after pharmaceutical giant AstraZeneca put its phase three COVID-19 vaccine on hold after a woman in the United Kingdom reportedly suffered a rare spinal cord injury. AstraZeneca resumed its study days later.
See full story here.